Method of delaying the onset of diabetes

Details Method of delaying the onset of diabetes Method of delaying the onset of diabetes

2006-02-07

2006-02-07

Nguyen, Dave Trong (Department: 1632)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C536S023400, C536S023500, C424S093100

Reexamination Certificate

active

06995147

ABSTRACT:
A method for preventing, delaying the onset of or treating diabetes in a patient comprising selecting a patient who is susceptible to developing diabetes, who is developing diabetes or who is diabetic and administering to the patient one or more than one dose of a pharmaceutical agent comprising a polynucleotide encoding a secreted exogenous protein, such as a secreted luciferase or a secreted form of human glutamic acid decarboxylase.

REFERENCES:
patent: 6001360 (1999-12-01), Atkinson et al.
patent: 6022697 (2000-02-01), Kaufman et al.
patent: 0 519 469 (1992-12-01), None
patent: WO 92/15673 (1992-09-01), None
Deonarain (1998) Exp. Opin. Ther. Pat., 8(1): 53-69.
Gorecki (2001) Exp. Opin. Emerging Drugs, 6(2): 187-98.
Verma, et al. (1997) Nature, 389: 239-42.
Eck, et al. (1996) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., McGraw-Hill, New York, NY., pp. 77-101.
Bowman, et al. (1994) Immunology Today, 15(3): 115-20.
Filippova, et al. (2001) DNA Cell. Biol., 20(3):175-81.
Winer, et al. (2002) J. Immunol., 168: 475-82.
Cao, et al. (2004) J. Clin. Endocrinol. Metabol., 89(2): 898-903.
Geng et al., “Widespread Expression of an Autoantigen-GAD65 Transgene Does Not Tolerize Non-Obese Diabetic Mice and Can Exacerbate Disease,” Pro. Natl. Acad. Sci., USA, Aug. 1998, vol. 95, pp. 10055-10060.
Liu et al. “Intramuscular Injection of Plasmid DNA Encoding Intracellular or Secreted Glutamic Acid Decarboxylase Causes Decreased Insulitis in the Non-Obese Diabetic Mouse,” Gene Ther. Mol. Biol., vol. 3, pp. 197-206, Aug. 1999.
Quintana et al., “Vaccination with Empty Plasmid DNA or CpG Oligonucleotide Inhibits Diabetes in Nonobese Diabetic Mice: Modulation of Spontaneous 60-kDA Heat Shock Protein Autommunity,” J. Immunol., 2000, 165:6148-6155.
Sai et al., “Immunization of Non-Obese Diabetic (NOD) Mice with Glutamic Acid Decarboxylase-Derived Peptide 524-543 Reduces Cylophosphamide-Accelarated Diabetes,” Clin. Exp. Immunol., Aug. 1996, vol. 105, No. 2, pp. 330-337.
Tisch et al., “Administering Glutamic Acid Decarboxylase to NOD Mice Prevents Diabetes,” J. Autoimmun., 1994, vol. 7, pp. 845-850.
Tisch et al., “Antigen-Specific Mediated Suppression of β Cell Autoimmunity by Plasmid DNA Vaccination,” J. Immunol., 2001, 166:2122-2132.
Weist-Ladenburger et al., “DNA Vaccination with Glutamic Acid Decarboxylase (GAD) Generates a Strong Humoral Immunuel Response in BALB/c, C57Bl/67, and Diabetes-Prone Mice, ” Homr. Metab. Res. 1998, vol. 30, pp. 605-609.
Filippova et al., “Effects of plasmid DNA injection on cyclophosphamide-accelerated diabetes in NOD mice.” DNA and Cell Biology, vol. 20, No. 3, 2001, pp. 175-181.
Roll U. et al., “DNA vaccination with plasmids containing GAD65 and/or interleukin-4 cDNA: No effect on the incidence of diabetes in NOD mice,” Diabetologia, vol. 41, No. Suppl. 1, Aug. 1998, p. A87
Lorenz et al., “Isolation and Expression of a cDNA Encodig Renilla Reniformis Luciferase,” Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington, US, vol. 88, May 1991, pp. 4438-4442.

Affiliated with

Also associated with

Rating

Method of delaying the onset of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of delaying the onset of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of delaying the onset of diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3687497